About IBCHN
The Making of the IBCHN
The IBCHN is an independent Research Institute originating from the seminal discoveries in the 1970s on the specific omega 6 and omega 3, essential fatty acid (EFA) requirement for the brain. This work was funded by the MRC. The research group that was to become the IBCHN was led by Professor Michael Crawford who was head of the Department of Biochemistry in the Nuffield Institute of Comparative Medicine, a research section of the Zoological Society of London.
Owing to the need to apply the discovery to focus on the high specialisation of human neurodevelopment, the IBCHN was formalized in 1989 by a council that included Lord Rea, Sir Michael Marmot, , Margaret Wynn, Ian-Dawson-Shepherd, Major Christopher Robinson, Professors Kate Costeloe, Gerry Shaper and Cedric Hassall with Dr Robert Lister who is the present chairman.
The application to human medicine was funded by the Wolfson Foundation. The work was then located in Hackney with its own funding. The objective was to better understand the relevance of nutrition to low birthweight because of the high, associated risk of neurodevelopmental disorder. It became a research arm and was funded by the newly formed Mother and Child Foundation with other support from national and international research funds.
The IBCHN was worked from the Hayward Research Building at the Queen Elizabeth Hospital for Children, Hackney. It trained post-graduates from the University of North London and in 1996 it was invited to join the University by Professor Ian Haines who was Dean of the Faculty Science and who following the merger with the Guildhall, became Director of Graduate School, London Metropolitan University.
The original discovery and the following papers demonstrating behavioural and neural consequences of deficits of the EFA, won several international prizes and firmly established the international reputation. Its work has provided a better understanding of the specific importance of arachidonic and docosahexaenoic acids in neurodevelopment and function. It collaborates with several national and international research groups and is currently being consulted by WHO and FAO on EFA nutrition and the brain.
Mission
To understand how environmental factors, particularly nutrients influence human development and health.
Specific Objectives
- Interaction between nutrition and biological systems.
- Maternal and fetal nutrition and the prevention of low birthweight and associated handicap.
- Causes and prevention of brain disorders.
The laboratory centred basic and applied research activities at the IBCHN are primarily on lipid and membrane biochemistry in relation to development and health.
The work of the IBCHN is monitored, regulated and evaluated by an external advisory board whose members are experts in diverse scientific disciplines.
Organisations that have supported our research endeavours include:
Vifor Pharma; Efamol Ltd/Wassen International; Kitchener Fund; European Commission - Marie Curie Actions (Contract No. 29914) ; Down's Syndrome Research Foundation ; Prisoners of Conscience ; The Foyle Foundation ; Equazen Ltd. ; Letten Foundation ; Food Standards Agency ; The Henry Lester Trust Limited ; The AOCS Foundation American Oil Chemists Society ; EU Research Promotion Foundation ; The Henry Smith Trust ; Diabetes UK ; Kellogg's Co. ; Laing Trust; March of Dimes Birth Defect Foundation ; Martek Biosciences ; Milupa Plc. ; Ministry of Agriculture, Food and Fisheries (MAFF) ; NATO ; Nutricia ; Roche UK ; Scientific Hospital Supplies ; Shida Kanzume Co. ; Sir Halley Stewart Trust ; St Bartholomew's & the Royal London School of Medicine Research Board ; The Christopher H. R. Reeves Charitable Trust ; The Mother and Child Foundation ; The Royal Society ; The Wellcome Trust ; The Worshipful Company of Innholders ; Wolfson Foundation ; Yews Trust.
